Lindsey George

Assistant Professor (Tenure Track)

University of Pennsylvania Perelman School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lindsey George is an Assistant Professor (Tenure Track) at the University of Pennsylvania Perelman School of Medicine, USA. Her research focuses on gene therapy and immune modulation in relation to hemophilia, specifically investigating the biological mechanisms of coagulation factor VIII and its implications for emerging therapies. Recent publications include studies on novel gene therapies and the immunogenicity of immune modulators in bleeding disorders.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Moanaro Biswas

Assistant Professor

Indiana State University

UNITED STATES

View details

Guy Young

UNITED STATES

View details

Shannon Boye

Professor

University of Florida

UNITED STATES

View details

Louise Rodino-Klapac

Chief Scientific Officer

UNITED STATES

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lindsey George

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies

Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab

Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice

Coagulation Factor VIII: Biological Basis of Emerging Hemophilia A Therapies

Roctavian Gene Therapy for Hemophilia A

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding

Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.

Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells.

Hemophilia A Gene Therapy - Some Answers, More Questions.

Total Knee Arthroplasty after Gene Therapy for Hemophilia B.

Adeno-associated Virus Gene Therapy for Hemophilia.

Factor IX Padua for haemophilia B gene addition: universal adaptation and repeated success.

Hemophilia gene therapy: ushering in a new treatment paradigm?

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.

Haemophilia care: the only constant is change.

Activated protein C has a regulatory role in factor VIII function

Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua.

No CpGs for AAVs?

Current Clinical Applications of In Vivo Gene Therapy with AAVs.

Collaborators (10)

Moanaro Biswas

Guy Young

Shannon Boye

Louise Rodino-Klapac

Benjamin J. Samelson‐Jones

Noritaka Yada

Glaivy Batsuli

Michelle M. Martinez-Irizarry

Margaret Ragni

Jordan A. Shavit

Make your next move.